Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S E Order

Showing results (91-100 of 135) with videos related to

Pageof 14
Sort By:
Cancer|June 1, 1982
CT scan modification in the treatment of mediastinal Hodgkin's diseaseR A Rostock, A Giangreco, M D Wharam, et al.
Cancer|July 15, 1981
The integration of new therapies and radiation in the management of ovarian cancerS E Order, N Rosenshein, J L Klein, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1986
90Yttrium antiferritin--a new therapeutic radiolabeled antibodyS E Order, J L Klein, P K Leichner, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1985
Improving the therapeutic ratio of external beam irradiation for carcinoma of the prostateJ D Forman, E Zinreich, D J Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1989
A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04)D J Lee, T F Pajak, J Stetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancerJ V Sitzmann, S E Order, J L Klein, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1985
A model system that predicts effective half-life for radiolabeled antibody therapyJ L Klein, M N Ling, P K Leichner, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Dosimetry and treatment planning in radioimmunotherapyP K Leichner, N C Yang, B W Wessels, et al.
Cancer Treatment Reports|February 1, 1982
Phase I-II study of isotopic immunoglobulin therapy for primary liver cancerD S Ettinger, S E Order, M D Wharam, et al.
Cancer|October 15, 1986
The correlation of pretreatment transurethral resection of prostatic cancer with tumor dissemination and disease-free survival. A univariate and multivariate analysisJ D Forman, S E Order, E S Zinreich, et al.
Pageof 14

Showing results (91-100 of 135) with videos related to

Sort By:
Pageof 14
Cancer|June 1, 1982
CT scan modification in the treatment of mediastinal Hodgkin's diseaseR A Rostock, A Giangreco, M D Wharam, et al.
Cancer|July 15, 1981
The integration of new therapies and radiation in the management of ovarian cancerS E Order, N Rosenshein, J L Klein, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1986
90Yttrium antiferritin--a new therapeutic radiolabeled antibodyS E Order, J L Klein, P K Leichner, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 1985
Improving the therapeutic ratio of external beam irradiation for carcinoma of the prostateJ D Forman, E Zinreich, D J Lee, et al.
International Journal of Radiation Oncology, Biology, Physics|February 1, 1989
A phase I/II study of the hypoxic cell sensitizer misonidazole as an adjunct to high fractional dose radiotherapy in patients with unresectable squamous cell carcinoma of the head and neck: a RTOG randomized study (#79-04)D J Lee, T F Pajak, J Stetz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1987
Conversion by new treatment modalities of nonresectable to resectable hepatocellular cancerJ V Sitzmann, S E Order, J L Klein, et al.
International Journal of Radiation Oncology, Biology, Physics|August 1, 1985
A model system that predicts effective half-life for radiolabeled antibody therapyJ L Klein, M N Ling, P K Leichner, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
Dosimetry and treatment planning in radioimmunotherapyP K Leichner, N C Yang, B W Wessels, et al.
Cancer Treatment Reports|February 1, 1982
Phase I-II study of isotopic immunoglobulin therapy for primary liver cancerD S Ettinger, S E Order, M D Wharam, et al.
Cancer|October 15, 1986
The correlation of pretreatment transurethral resection of prostatic cancer with tumor dissemination and disease-free survival. A univariate and multivariate analysisJ D Forman, S E Order, E S Zinreich, et al.
Pageof 14